Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2023 Filed Apr 7, 2023 16:43 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 6,967 | $2.14 | $14,923.31 |
DisclosureSEC source: 0001209191-23-023809 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 16:42 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,961 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-023806 · doc4.xml · derivative · entry 5 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 367,942 Underlying: Common Stock · 6,961 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 16:42 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 6,961 | $5.00 | $34,805.00 |
DisclosureSEC source: 0001209191-23-023806 · doc4.xml · nonDerivative · entry 2 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 16:42 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,961 | $0.04 | $278.44 |
DisclosureSEC source: 0001209191-23-023806 · doc4.xml · nonDerivative · entry 1 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 340,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,266 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · derivative · entry 9 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,162 Underlying: Common Stock · 7,266 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · derivative.exercise_date: The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 7,266 | $5.03 | $36,547.98 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · nonDerivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 7,266 | $2.14 | $15,563.77 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · nonDerivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,470 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · derivative · entry 9 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 374,903 Underlying: Common Stock · 7,470 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 7,470 | $5.03 | $37,574.10 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · nonDerivative · entry 6 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 7,470 | $0.04 | $298.80 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · nonDerivative · entry 5 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 340,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · derivative · entry 8 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,428 Underlying: Common Stock · 100 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · derivative.exercise_date: The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 100 | $5.01 | $501.00 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 100 | $2.14 | $214.20 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · derivative · entry 8 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 382,373 Underlying: Common Stock · 100 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 100 | $5.01 | $501.00 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · nonDerivative · entry 4 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 100 | $0.04 | $4.00 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · nonDerivative · entry 3 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 333,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,607 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · derivative · entry 7 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,528 Underlying: Common Stock · 2,607 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · derivative.exercise_date: The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 2,607 | $5.00 | $13,035.00 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 19:00 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 2,607 | $2.14 | $5,584.19 |
DisclosureSEC source: 0001209191-23-022988 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,607 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · derivative · entry 7 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 382,473 Underlying: Common Stock · 2,607 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 2,607 | $5.00 | $13,035.00 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · nonDerivative · entry 2 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:59 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 2,607 | $0.04 | $104.28 |
DisclosureSEC source: 0001209191-23-022983 · doc4.xml · nonDerivative · entry 1 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 335,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 13:11 UTC |
DOUGLAS RICHARDDirector
|
PurchaseCommon Stock | 80,000 | $4.32 | $345,480.00 |
DisclosureSEC source: 0001209191-23-021573 · doc4.xml · nonDerivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 27, 2023 Filed Mar 28, 2023 14:06 UTC |
Swirsky Douglas JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0001209191-23-021333 · doc4.xml · derivative · entry 1 Swirsky Douglas J · CIK 0001375884 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2033-03-26 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 27, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 16:42 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020287 · doc4.xml · derivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 16:43 UTC |
Masoud MaherEVP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020289 · doc4.xml · derivative · entry 1 Masoud Maher · CIK 0001874571 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 16:46 UTC |
Holtz RonChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020298 · doc4.xml · derivative · entry 1 Holtz Ron · CIK 0001874490 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 16:42 UTC |
Doerfler DouglasDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020285 · doc4.xml · derivative · entry 1 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:45 UTC |
Hemrajani RekhaDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020293 · doc4.xml · derivative · entry 1 Hemrajani Rekha · CIK 0001771213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: This grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 23,333 of the shares underlying this option vested on March 20, 2023 and the remaining 16,667 shares will vest in 15 equal monthly installments thereafter, beginning on April 14, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:44 UTC |
Al-Wakeel Yasir B.Director
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020291 · doc4.xml · derivative · entry 1 Al-Wakeel Yasir B. · CIK 0001650691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-03-19 F1 · derivative.exercise_date: This grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 23,333 of the shares underlying this option vested on March 20, 2023 and the remaining 16,667 shares will vest in 15 equal monthly installments thereafter, beginning on April 14, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:41 UTC |
Sumen CenkChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001209191-23-020283 · doc4.xml · derivative · entry 2 Sumen Cenk · CIK 0001917133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-03-19 F3 · derivative.exercise_date: 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,575 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · derivative · entry 8 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,135 Underlying: Common Stock · 11,575 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 11,575 | $5.77 | $66,787.75 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · nonDerivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.69 to $5.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 11,575 | $2.14 | $24,793.65 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:31 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,665 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-006876 · doc4.xml · derivative · entry 6 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,080 Underlying: Common Stock · 10,665 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:31 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 10,665 | $5.77 | $61,537.05 |
DisclosureSEC source: 0001209191-23-006876 · doc4.xml · nonDerivative · entry 4 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.69 to $5.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:31 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,665 | $0.04 | $426.60 |
DisclosureSEC source: 0001209191-23-006876 · doc4.xml · nonDerivative · entry 3 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,090 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · derivative · entry 7 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,710 Underlying: Common Stock · 15,090 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,468 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · derivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,468 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 17,558 | $5.68 | $99,729.44 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.51 to $5.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 15,090 | $2.14 | $32,322.78 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:32 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 2,468 | $0.98 | $2,426.04 |
DisclosureSEC source: 0001209191-23-006880 · doc4.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:31 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,335 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-006876 · doc4.xml · derivative · entry 5 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,745 Underlying: Common Stock · 19,335 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:31 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 19,335 | $5.69 | $110,016.15 |
DisclosureSEC source: 0001209191-23-006876 · doc4.xml · nonDerivative · entry 2 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.50 to $5.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 16:31 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionCommon Stock | 19,335 | $0.04 | $773.40 |
DisclosureSEC source: 0001209191-23-006876 · doc4.xml · nonDerivative · entry 1 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. Read SEC document |
| January 05, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,467 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · derivative · entry 9 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468 Underlying: Common Stock · 9,467 shares Expires 2026-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 05, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
SaleCommon Stock | 9,467 | $5.04 | $47,713.68 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · nonDerivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 05, 2023 Filed Jan 5, 2023 17:31 UTC |
Ross Thomas M.EVP, Global Sales & Marketing
|
Exercise / conversionCommon Stock | 9,467 | $0.98 | $9,306.06 |
DisclosureSEC source: 0001209191-23-001980 · doc4.xml · nonDerivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. Read SEC document |
| January 05, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,234 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · derivative · entry 9 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,080 Underlying: Common Stock · 10,234 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 05, 2023 Filed Jan 5, 2023 17:39 UTC |
Doerfler DouglasDirector · President and CEO
|
SaleCommon Stock | 10,234 | $5.04 | $51,579.36 |
DisclosureSEC source: 0001209191-23-001995 · doc4.xml · nonDerivative · entry 6 Doerfler Douglas · CIK 0001874482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,197 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2022 relating solely to the sale of shares acquired from exercise of an option that expires on November 11, 2024. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.